A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. To Evaluate the Safety and Effectiveness of ArtiFascia® in Subjects Requiring Dural Repair.

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

January 7, 2020

Primary Completion Date

November 1, 2022

Study Completion Date

November 1, 2022

Conditions
Dural TearCerebrospinal Fluid Leak
Interventions
DEVICE

Implantation of the ArtiFascia®

"Following are the general instructions for use for the ArtiFascia®:~* Cut the ArtiFascia® to the required shape under aseptic conditions~* Apply ArtiFascia® to the damaged area~* Suture the ArtiFascia® in place~* Suture bites should be taken 2-3 millimeters from the edges of the implant. Either a running suture or interrupted stitches' technique may be used, depending on clinical conditions or surgeon's decision.~Important Note: If clinically possible, do not use dural adhesive or sealants as it is an uncontrolled variable, that can influence the results."

DEVICE

Implantation of other commercial suturable dural substitute

Implantation of the commercial suturable dural substitute will be according to clinical discretion of the physician, and in compliance with each specific device instructions for use. Detailed instructions are in the instructions for use

Trial Locations (9)

49100

Rabin Medical Center (Beilinson, Hasharon), Petah Tikva

B-3600

Ziekenhuis Oost-Limburg, Genk

656 91

St. Anne's University Hospital Brno, Brno

779 00

Neurochirurgická klinika Přednosta FN Olomouc, Olomouc

80-214

Medical University of Gdańsk, Gdansk

90-153

Barlicki University Hospital, Lodz

08035

Hospital Universitari Vall d'Hebron, Barcelona

08036

Hospital Clinic de Barcelona, Barcelona

09807

Hospital Universitario de Bellvitge, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nurami Medical Ltd

OTHER